CHERRY SE |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.295 EUR | +14.75% |
|
+15.21% | -27.94% |
| Apr. 02 | Upheaval at keyboard manufacturer Cherry | DP |
| Mar. 11 | Cherry SE Launches Disinfectable Mouse and Keyboard Set for Hygiene-Sensitive Areas at HIMSS | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 605.1 | 179.3 | 53.22 | 53.22 | - |
| Enterprise Value (EV) 1 | 513.9 | 103.3 | 59.27 | 63.25 | 61.07 |
| P/E ratio | 59.3 x | -5.09 x | -2.11 x | -7.4 x | -18 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 3.59 x | 1.35 x | 0.42 x | 0.38 x | 0.36 x |
| EV / Revenue | 3.05 x | 0.78 x | 0.46 x | 0.46 x | 0.41 x |
| EV / EBITDA | 12 x | 8.47 x | -14.5 x | 6.97 x | 4.32 x |
| EV / FCF | -77.7 x | -25.8 x | -2.02 x | -26.1 x | 16 x |
| FCF Yield | -1.29% | -3.88% | -49.5% | -3.83% | 6.26% |
| Price to Book | 2.06 x | 0.7 x | 0.23 x | 0.24 x | 0.24 x |
| Nbr of stocks (in thousands) | 24,300 | 23,650 | 23,190 | 23,190 | - |
| Reference price 2 | 24.90 | 7.580 | 2.295 | 2.295 | 2.295 |
| Announcement Date | 3/31/22 | 3/30/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net sales 1 | 168.5 | 132.5 | 128 | 138.6 | 149.1 |
| EBITDA 1 | 42.8 | 12.2 | -4.1 | 9.075 | 14.15 |
| EBIT 1 | 33.7 | -3.1 | -26.3 | -6.7 | -1.95 |
| Operating Margin | 20% | -2.34% | -20.55% | -4.83% | -1.31% |
| Earnings before Tax (EBT) 1 | 13.49 | -38.35 | -32.67 | -7.767 | -4.333 |
| Net income 1 | 9.287 | -35.73 | -25.85 | -7.375 | -3.1 |
| Net margin | 5.51% | -26.96% | -20.2% | -5.32% | -2.08% |
| EPS 2 | 0.4200 | -1.490 | -1.090 | -0.3100 | -0.1275 |
| Free Cash Flow 1 | -6.612 | -4.009 | -29.32 | -2.425 | 3.825 |
| FCF margin | -3.92% | -3.03% | -22.91% | -1.75% | 2.56% |
| FCF Conversion (EBITDA) | - | - | - | - | 27.03% |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 3/31/22 | 3/30/23 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2022 Q1 | 2022 Q2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 43.1 | 33 | 32.9 | 28.7 | 32.61 | 61.31 | 27.3 | 36.8 |
| EBITDA | - | 12.3 | 4.4 | - | - | - | - | - | - |
| EBIT | - | - | 0.5 | - | -5.1 | 0.853 | -5.704 | - | - |
| Operating Margin | - | - | 1.52% | - | -17.77% | 2.62% | -9.3% | - | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - |
| Net income | -4.896 | - | - | - | -5.321 | 0.288 | -5.034 | - | - |
| Net margin | - | - | - | - | -18.54% | 0.88% | -8.21% | - | - |
| EPS | -0.2400 | - | - | - | -0.2300 | 0.0100 | -0.2200 | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/16/21 | 11/15/21 | 5/11/22 | 8/11/22 | 5/15/23 | 8/14/23 | 8/14/23 | 11/15/23 | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | 6.05 | 10 | 7.85 |
| Net Cash position 1 | 91.1 | 75.9 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | -1.476 x | 1.105 x | 0.5548 x |
| Free Cash Flow 1 | -6.61 | -4.01 | -29.3 | -2.43 | 3.83 |
| ROE (net income / shareholders' equity) | 4.26% | -13.1% | -11.3% | -3.43% | -1.58% |
| ROA (Net income/ Total Assets) | - | -9.04% | -9.1% | -3.7% | -1.6% |
| Assets 1 | - | 395 | 284.1 | 199.3 | 193.8 |
| Book Value Per Share 2 | 12.10 | 10.80 | 9.870 | 9.710 | 9.700 |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | 14.4 | 9.78 | 14.4 | 13.5 | 13.2 |
| Capex / Sales | 8.56% | 7.38% | 11.25% | 9.7% | 8.87% |
| Announcement Date | 3/31/22 | 3/30/23 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
2.295
EUR
Average target price
3.867
EUR
Spread / Average Target
+68.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -27.94% | 56.82M | |
| +29.68% | 5.77B | |
| +15.71% | 4.5B | |
| -10.50% | 1.44B | |
| -3.85% | 1.42B | |
| +29.10% | 1.24B | |
| +10.64% | 1.2B | |
| +6.26% | 1.07B | |
| +102.67% | 805M | |
| +1.01% | 652M |
- Stock Market
- Equities
- C3RY Stock
- Financials Cherry SE
